The first VANGUARD meeting has been scheduled in Innsbruck, Austria for the 25th January 2020. Representatives from the 9 partners will travel to meet together for the first time to officially kick-off the VANGUARD project.
The project will run for 5 years and aims at delivering an Advanced Therapeutic Medicinal Product (ATMP) of high translational potential, with properties of increased functionality and implantability and protection from immune destruction. During the first meeting the partners will have the opportunity to introduce themselves and their role within the project which will contribute to the efficient implementation of the planned research and measures. We look forward to meeting the team who are taking part in this innovative project.